Phase 3 Chemotherapy-induced Peripheral Neuropathy (CIPN) trials recruiting now

All Chemotherapy-induced Peripheral Neuropathy (CIPN) trials, every phase

Phase 3 Chemotherapy-induced Peripheral Neuropathy (CIPN) trials

• GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer
  NCT06994507 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Gut Microbiome Profiles in Patients with Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).
  NCT06799351 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy
  NCT06706544 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.